Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C Levy

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 29, 2017
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatmentAafke C van der Heijden, Johannes B van Rees, Wayne C Levy, et al.
The American Journal of Medicine|April 10, 2020
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection FractionPhillip H Lam, Milton Packer, Gauravpal S Gill, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist DeviceScott C Silvestry, Claudius Mahr, Mark S Slaughter, et al.
European Journal of Heart Failure|May 23, 2012
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN TrialTomasz Siminiak, Justina C Wu, Michael Haude, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist DeviceClaudius Mahr, Edwin McGee, Anson Cheung, et al.
Journal of Cardiac Failure|December 15, 2022
Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean CohortPau Codina, Elisabet Zamora, Wayne C Levy, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 29, 2017
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatmentAafke C van der Heijden, Johannes B van Rees, Wayne C Levy, et al.
The American Journal of Medicine|April 10, 2020
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection FractionPhillip H Lam, Milton Packer, Gauravpal S Gill, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Journal of the American College of Cardiology|May 27, 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsKenneth C Bilchick, Yongfei Wang, Alan Cheng, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist DeviceScott C Silvestry, Claudius Mahr, Mark S Slaughter, et al.
European Journal of Heart Failure|May 23, 2012
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN TrialTomasz Siminiak, Justina C Wu, Michael Haude, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist DeviceClaudius Mahr, Edwin McGee, Anson Cheung, et al.
Journal of Cardiac Failure|December 15, 2022
Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean CohortPau Codina, Elisabet Zamora, Wayne C Levy, et al.
Pageof 17